Given that AD exhibits sexual dimorphism in its prevalence, progression, and molecular mechanisms coupled with our findings on PR induced metabolic and pathological outcomes, we performed western blotting for the mitophagy marker BNIP3L/NIX79. This evidence concerns the gene BNIP3L and Alzheimer disease.